Attana and Linnaeus University commence the second phase of testing with Region Kalmar
Attana has received ~300 post-vaccination patient blood samples from Region Kalmar to be analyzed using Attana’s Diagnostic immunoassay. The samples have been delivered to the lab at the Linnaeus University and will, among other things, be tested for different variants of the SARS-CoV-2 virus and the results will be published in a scientific paper. The study is not only expected to generate interesting results but will also further validate Attana’s unique technology applied in advanced diagnostics.